CorFlow Therapeutics is Diagnostic Equipment in Switzerland that focus on flow infusion business. Founded in 2016. They cover business area such as developer, microvascular obstruction, (CoFITM) system, (MVO, (dmvrtm, these peri-procedural dmvr value, to post-procedure contrast-enhance Magnetic Resonance Imaging, MRI, interventional cardiologist, severe heart attack patient, these patient.
2016
( 8 years old in 2024 )
Flow Infusion
-
Neuhofstrasse 3d
6340 Baar
Switzerland
Private
developermicrovascular obstruction(CoFITM) system(MVO(dmvrtmthese peri-procedural dmvr valueto post-procedure contrast-enhance Magnetic Resonance ImagingMRIinterventional cardiologistsevere heart attack patientthese patient
* We use standard office opening hours in near CorFlow Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
CorFlow Therapeutics is Diagnostic Equipment business from Switzerland that founded in 2016 (8 years old in 2024), CorFlow Therapeutics business is focusing on Flow Infusion.
CorFlow Therapeutics headquarter office and corporate office address is located in Neuhofstrasse 3d 6340 Baar Switzerland.
CorFlow Therapeutics was founded in Switzerland.
In 2024, CorFlow Therapeutics is currently focus on flow infusion sector.
Above is snippet of Google Trends for "flow infusion" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with CorFlow Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.